Skip to content
Tenfell
Awarded contract
Published 28 May 2026

Medical genetic testing kits

Cardiff and Vale University Health Board · Wales

Key facts

Contract value
£96,000
Awarded
02 Jan 2026
Contract starts
03 Jan 2026
Contract ends
02 Jan 2028
Procedure
Below threshold - without competition
Buyer type
Health

Awarded to

SupplierValue
MRC Holland BV£96,000

Description

The All Wales Medical Genomics Service (AWMGS) has routinely utilised Multiplex Ligation-Dependent Probe Amplification (MLPA) as a diagnostic tool for identifying Copy Number Variations (CNVs)—including deletions and duplications—across a range of genetic disorders. This testing supports clinical decision-making and patient treatment strategies.MLPA technology involves the use of oligonucleotide probe pairs that hybridise to specific DNA sequences within target genes. When both probes bind adjacently at a site of interest, they are ligated and subsequently amplified via Polymerase Chain Reaction (PCR). The amplified DNA fragments are then separated by capillary electrophoresis and analysed to detect CNVs.Since its inception, AWMGS has exclusively sourced MLPA probes and reagents from MRC Holland, a Netherlands-based supplier recognised for its specialised products in molecular diagnostics.

Categories (CPV)

Similar open tenders

About Cardiff and Vale University Health Board

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.